QubeHealth, a Mumbai, India-based healthcare funds firm, raised an undsclosed quantity in Pre-Sequence A funding, at Rs. 270 Crore valuation.
The spherical was led by Unicorn India Ventures and CanBank VC.
The corporate intends to make use of the funds to spend money on know-how and new options, together with embedded insurance coverage, a generative AI-led advice engine, and a healthcare market.
Led by CEO Chris George, QubeHealth is a healthcare funds firm integrating a ‘funds infrastructure’, interest-free healthcare financing, medical insurance, and healthcare suppliers. Its customers are staff of Indian firms who’ve subscribed to Qube’s healthcare cost merchandise for his or her staff, normally as an add-on to their company group medical insurance plan. Staff (customers) will pay any healthcare supplier (hospitals, clinics, pharmacies, and many others.) throughout India by way of its cell software (“QubePay”), with no restrictions on healthcare supplier networks or restrictions on relations.
Qube’s person base contains staff and their households from over 300 giant Indian corporates, comparable to Flipkart and Tata-Teleservices. The corporate is in search of to lift $9m in its upcoming Sequence-A spherical.
FinSMEs
05/11/2024
